Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.90)
# 261
Out of 4,579 analysts
313
Total ratings
56.3%
Success rate
31.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELOX Eloxx Pharmaceuticals | Initiated Coverage: Buy | $40 | $12.11 | +230.31% | 1 | Jul 22, 2026 | |
| MANE Veradermics | Maintained: Buy | $170 | $111.42 | +52.58% | 3 | Jul 18, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $90 | $35.18 | +155.83% | 38 | Jul 11, 2026 | |
| VRDN Viridian Therapeutics | Rated: Buy | $35 | $19.70 | +77.66% | 47 | Jun 29, 2026 | |
| ELDN Eledon Pharmaceuticals | Maintained: Buy | $8 | $3.57 | +124.09% | 41 | Jun 27, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $33 | $19.88 | +66.00% | 41 | Jun 22, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $100 | $74.61 | +34.03% | 38 | Jun 15, 2026 | |
| DNTH Dianthus Therapeutics | Rated: Buy | $125 | $104.49 | +19.63% | 23 | Jun 12, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $42 | $19.95 | +110.53% | 4 | Jun 6, 2026 | |
| MLYS Mineralys Therapeutics | Rated: Buy | $54 | $27.21 | +98.46% | 24 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $19.49 | +23.14% | 13 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $28.69 | +98.68% | 6 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.60 | +204.35% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.56 | - | 22 | Aug 14, 2025 |
Eloxx Pharmaceuticals
Jul 22, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $12.11
Upside: +230.31%
Veradermics
Jul 18, 2026
Maintained: Buy
Price Target: $170
Current: $111.42
Upside: +52.58%
Vera Therapeutics
Jul 11, 2026
Maintained: Buy
Price Target: $90
Current: $35.18
Upside: +155.83%
Viridian Therapeutics
Jun 29, 2026
Rated: Buy
Price Target: $35
Current: $19.70
Upside: +77.66%
Eledon Pharmaceuticals
Jun 27, 2026
Maintained: Buy
Price Target: $8
Current: $3.57
Upside: +124.09%
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $33
Current: $19.88
Upside: +66.00%
Disc Medicine
Jun 15, 2026
Maintained: Buy
Price Target: $100
Current: $74.61
Upside: +34.03%
Dianthus Therapeutics
Jun 12, 2026
Rated: Buy
Price Target: $125
Current: $104.49
Upside: +19.63%
Jade Biosciences
Jun 6, 2026
Maintained: Buy
Price Target: $42
Current: $19.95
Upside: +110.53%
Mineralys Therapeutics
Jun 1, 2026
Rated: Buy
Price Target: $54
Current: $27.21
Upside: +98.46%
May 16, 2026
Maintained: Buy
Price Target: $24
Current: $19.49
Upside: +23.14%
May 16, 2026
Maintained: Buy
Price Target: $57
Current: $28.69
Upside: +98.68%
Mar 31, 2026
Maintained: Buy
Price Target: $14
Current: $4.60
Upside: +204.35%
Aug 14, 2025
Maintained: Hold
Price Target: n/a
Current: $28.56
Upside: -